TG THERAPEUTICS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
TG THERAPEUTICS, INC. (TGTX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $2.72 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-11-12
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$12.55M.
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$7.12M, a 130.39% decline year-over-year.
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $22.39M, a 14.46% decline year-over-year.
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$28.76M.
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$14.11M, a 144.51% decline from fiscal 2017.
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $31.69M.
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$30.03M.
- TG THERAPEUTICS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2015 was -$652.46K, a 104.28% decline from fiscal 2014.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 3 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 13 month | Cash and Cash Equivalents, Period Increase (Decrease) 15 month | Cash and Cash Equivalents, Period Increase (Decrease) 16 month | Cash and Cash Equivalents, Period Increase (Decrease) 18 month | Cash and Cash Equivalents, Period Increase (Decrease) 19 month | Cash and Cash Equivalents, Period Increase (Decrease) 22 month | Cash and Cash Equivalents, Period Increase (Decrease) 25 month | Cash and Cash Equivalents, Period Increase (Decrease) 28 month | Cash and Cash Equivalents, Period Increase (Decrease) 119 month | Cash and Cash Equivalents, Period Increase (Decrease) 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | -$12.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$19.67M derived: sum of 2 quarters · filed 2019-11-12 | $2.72M 10-Q · filed 2019-11-12 | -$26.03M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||
| 2019-06-30 | -$7.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $15.28M 10-Q · filed 2019-08-09 | -$13.48M derived: sum of 3 quarters · filed 2019-08-09 | -$48.44M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||
| 2019-03-31 | $22.39M 10-Q · filed 2019-05-10 | -$6.36M derived: sum of 2 quarters · filed 2019-05-10 | -$41.32M derived: sum of 3 quarters · filed 2019-11-12 | -$17.89M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||
| 2018-12-31 | -$28.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$63.71M derived: sum of 2 quarters · filed 2019-11-12 | -$40.28M derived: sum of 3 quarters · filed 2019-11-12 | -$14.11M 10-K · filed 2019-03-01 | ||||||||||||||
| 2018-09-30 | -$34.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$11.53M derived: sum of 2 quarters · filed 2019-11-12 | $14.65M 10-Q · filed 2019-11-12 | -$20.47M derived: sum of 4 quarters · filed 2019-11-12 | ||||||||||||||
| 2018-06-30 | $23.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $49.60M 10-Q · filed 2019-08-09 | $14.48M derived: sum of 3 quarters · filed 2019-08-09 | $28.72M derived: sum of 4 quarters · filed 2019-08-09 | ||||||||||||||
| 2018-03-31 | $26.18M 10-Q · filed 2019-05-10 | -$8.94M derived: sum of 2 quarters · filed 2019-05-10 | $5.30M derived: sum of 3 quarters · filed 2019-05-10 | -$12.74M derived: sum of 4 quarters · filed 2019-05-10 | ||||||||||||||
| 2017-12-31 | -$35.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$20.88M derived: sum of 2 quarters · filed 2019-03-01 | -$38.92M derived: sum of 3 quarters · filed 2019-03-01 | $31.69M 10-K · filed 2019-03-01 | $31.69M 10-K · filed 2018-03-15 | |||||||||||||
| 2017-09-30 | $14.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$3.79M derived: sum of 2 quarters · filed 2018-11-09 | $66.81M 10-Q · filed 2018-11-09 | $66.81M 10-Q · filed 2017-11-09 | $62.69M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2017-06-30 | -$18.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $52.57M 10-Q · filed 2018-08-09 | $52.57M 10-Q · filed 2017-08-09 | $48.45M derived: sum of 3 quarters · filed 2019-03-01 | $49.03M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2017-03-31 | $70.61M 10-Q · filed 2018-05-10 | $70.61M 10-Q · filed 2017-05-10 | $66.49M derived: sum of 2 quarters · filed 2019-03-01 | $67.07M derived: sum of 3 quarters · filed 2019-03-01 | $59.16M derived: sum of 4 quarters · filed 2019-03-01 | |||||||||||||
| 2016-12-31 | -$4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$3.54M derived: sum of 2 quarters · filed 2019-03-01 | -$11.44M derived: sum of 3 quarters · filed 2019-03-01 | -$30.03M 10-K · filed 2019-03-01 | -$30.03M 10-K · filed 2017-03-16 | |||||||||||||
| 2016-09-30 | $578.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$7.32M derived: sum of 2 quarters · filed 2017-11-09 | -$25.90M 10-Q · filed 2017-11-09 | -$36.31M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2016-06-30 | -$7.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$26.48M 10-Q · filed 2017-08-09 | -$36.88M derived: sum of 3 quarters · filed 2018-03-15 | -$31.72M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2016-03-31 | -$18.58M 10-Q · filed 2017-05-10 | -$28.98M derived: sum of 2 quarters · filed 2018-03-15 | -$23.82M derived: sum of 3 quarters · filed 2018-03-15 | -$49.53M derived: sum of 4 quarters · filed 2018-03-15 | ||||||||||||||
| 2015-12-31 | -$10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | -$5.24M derived: sum of 2 quarters · filed 2018-03-15 | -$30.94M derived: sum of 3 quarters · filed 2018-03-15 | -$652.46K 10-K · filed 2018-03-15 | ||||||||||||||
| 2015-09-30 | $5.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$20.54M derived: sum of 2 quarters · filed 2016-11-09 | $9.75M 10-Q · filed 2016-11-09 | $12.24M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-06-30 | -$25.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $4.59M 10-Q · filed 2016-08-09 | $7.07M derived: sum of 3 quarters · filed 2017-03-16 | $23.22M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2015-03-31 | $30.29M 10-Q · filed 2016-05-10 | $32.78M derived: sum of 2 quarters · filed 2017-03-16 | $48.93M derived: sum of 3 quarters · filed 2017-03-16 | $36.41M derived: sum of 4 quarters · filed 2017-03-16 | ||||||||||||||
| 2014-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $18.64M derived: sum of 2 quarters · filed 2017-03-16 | $6.12M derived: sum of 3 quarters · filed 2017-03-16 | $15.23M 10-K · filed 2017-03-16 | ||||||||||||||
| 2014-09-30 | $16.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $3.63M derived: sum of 2 quarters · filed 2015-11-09 | $12.74M 10-Q · filed 2015-11-09 | $3.04M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-06-30 | -$12.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$3.41M 10-Q · filed 2015-08-10 | -$13.11M derived: sum of 3 quarters · filed 2016-03-15 | $23.66M derived: sum of 4 quarters · filed 2016-03-15 | ||||||||||||||
| 2014-03-31 | $9.11M 10-Q · filed 2015-05-11 | -$587.07K derived: sum of 2 quarters · filed 2016-03-15 | $36.18M derived: sum of 3 quarters · filed 2016-03-15 | $34.41M derived: sum of 4 quarters · filed 2016-03-15 | $49.60M 10-Q · filed 2014-05-14 | |||||||||||||
| 2013-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $27.07M derived: sum of 2 quarters · filed 2016-03-15 | $25.30M derived: sum of 3 quarters · filed 2016-03-15 | $24.03M 10-K · filed 2016-03-15 | $40.49M 10-K · filed 2014-03-07 | |||||||||||||
| 2013-09-30 | $36.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $35.00M derived: sum of 2 quarters · filed 2014-11-14 | $33.73M 10-Q · filed 2014-11-14 | $32.81M derived: sum of 4 quarters · filed 2014-11-14 | $50.18M 10-Q · filed 2013-11-14 | |||||||||||||
| 2013-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$3.04M 10-Q · filed 2014-07-24 | -$3.96M derived: sum of 3 quarters · filed 2014-07-24 | -$6.95M derived: sum of 4 quarters · filed 2014-07-24 | $13.42M 10-Q · filed 2013-08-09 | |||||||||||||
| 2013-03-31 | -$1.27M 10-Q · filed 2014-05-14 | -$2.19M derived: sum of 2 quarters · filed 2014-05-14 | -$5.18M derived: sum of 3 quarters · filed 2014-05-14 | -$5.74M derived: sum of 4 quarters · filed 2014-05-14 | $15.19M 10-Q · filed 2013-05-14 | |||||||||||||
| 2012-12-31 | -$917.87K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$3.91M derived: sum of 2 quarters · filed 2014-03-07 | -$4.47M derived: sum of 3 quarters · filed 2014-03-07 | $6.71M 10-K · filed 2014-03-07 | $16.46M 10-K · filed 2013-03-21 | |||||||||||||
| 2012-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | -$3.55M derived: sum of 2 quarters · filed 2013-11-14 | $7.63M 10-Q · filed 2013-11-14 | $17.37M derived: sum of 4 quarters · filed 2013-11-14 | $17.37M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | -$556.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $10.62M 10-Q · filed 2013-08-09 | $20.37M derived: sum of 3 quarters · filed 2013-08-09 | $20.37M derived: sum of 4 quarters · filed 2013-08-09 | $20.37M 10-Q/A · filed 2012-09-07 | |||||||||||||
| 2012-03-31 | $11.18M 10-Q · filed 2013-05-14 | $20.92M derived: sum of 2 quarters · filed 2013-05-14 | $20.92M derived: sum of 3 quarters · filed 2013-05-14 | $20.92M 10-Q · filed 2012-05-14 | ||||||||||||||
| 2011-12-31 | $9.75M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $9.75M derived: sum of 2 quarters · filed 2013-03-21 | $9.75M 10-K · filed 2013-03-21 | |||||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | -$266.39K 10-Q · filed 2011-11-14 | $212.28K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 | $13.84K 10-Q/A · filed 2011-09-14 | $492.51K 10-Q/A · filed 2011-09-14 | |||||||||||||||
| 2010-09-30 | -$496.06K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $1.06M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | $1.55M 10-Q/A · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |